XERS Xeris Pharmaceuticals
- 1.935
- +0.045+2.38%
Xeris Pharmaceuticals News
Craig-Hallum Sticks to Their Buy Rating for Xeris Pharmaceuticals (XERS)
Xeris Biopharma Holdings Analyst Ratings
Oppenheimer Initiates Coverage On Xeris Biopharma Holdings With Outperform Rating, Announces Price Target of $5
Analysts Offer Insights on Healthcare Companies: Applied Therapeutics (APLT), Xeris Pharmaceuticals (XERS) and Arcturus Therapeutics (ARCT)
Xeris Biopharma Holdings Analyst Ratings
Analysts Offer Insights on Healthcare Companies: Xeris Pharmaceuticals (XERS), Aclaris Therapeutics (ACRS) and Quanterix (QTRX)
Analysts Offer Insights on Healthcare Companies: Vaxcyte (PCVX), Xeris Pharmaceuticals (XERS) and IN8bio (INAB)
Analysts Offer Insights on Healthcare Companies: Oric Pharmaceuticals (ORIC) and Xeris Pharmaceuticals (XERS)
Analysts Are Bullish on Top Healthcare Stocks: Avidity Biosciences (RNA), Xeris Pharmaceuticals (XERS)
HC Wainwright & Co. Maintains Buy on Xeris Biopharma Holdings, Lowers Price Target to $5.5
Xeris Biopharma Holdings Analyst Ratings
Piper Sandler Maintains Overweight on Xeris Biopharma Holdings, Lowers Price Target to $4-Report Released on 9th Nov 2023
Xeris Biopharma Holdings Analyst Ratings
Analysts Offer Insights on Healthcare Companies: Sensus Healthcare (SRTS), BioLife Solutions (BLFS) and Xeris Pharmaceuticals (XERS)
Xeris Pharmaceuticals (XERS) Gets a Buy From Piper Sandler
Xeris Pharmaceuticals (XERS) Gets a Buy From Craig-Hallum
Craig-Hallum Initiates Coverage On Xeris Biopharma Holdings With Buy Rating, Announces Price Target of $4.5
Xeris Biopharma Holdings Analyst Ratings
Xeris Biopharma Holdings Analyst Ratings
H.C. Wainwright Keeps Their Buy Rating on Xeris Pharmaceuticals (XERS)
Analysis
Price Target
No Data
